If this is your company, CONTACT US to activate Packbase™ software to build your portal.
News articles from Aptar Pharma.
Aptar Digital Health Announces Stallergenes Greer iPUMP Launch
Aptar Pharma highlights Innovative Drug Delivery Solutions at CPhI Europe
Aptar Pharma Launches First Metal-Free Highly Recyclable Nasal Spray Pump- Aptar Pharma Announces Collaboration with TFF Pharmaceuticals
- Aptar Pharma Completes First Phase of Global Injectables Expansion Program
- Aptar CSP Technologies to Preview Activ-Vial™ Technology with PCR (Post-Consumer-Recycled) Content at SupplySide West
- Aptar Pharma Acquires Worldwide License for Orbital™ High Payload Dry Powder Inhaler
- Aptar Mumbai Celebrates 10 Year Anniversary and Announces Construction of New Facility
- Aptar Pharma Launches HeroTracker Sense
- New FDA approved combination product with Aptar Pharma's VP3 nasal spray system
- Aptar Pharma Partners with Stallergenes Greer to Develop Novel Digital Health Ecosystem for Allergen Immunotherapy Treatment
- First Nasally-Administered Pharmaceutical Treatment for Dry Eye Disease Approved by US FDA with Aptar’s Nasal Pump System
- Aptar Pharma and i2c Pharmaceutical Services Announce Exclusive Partnership
- Aptar Pharma granted exclusive license option by Pharmaxis to develop and promote high payload dry powder inhaler
- Aptar Pharma & Noble partner with dne pharma on Ventizolve nasal Naloxone treatment
- Aptar Pharma acquires the assets of Cohero Health, further expanding its capabilities in digital health
- Noble and Aptar Pharma launch AdhereIT, a connected medical device solution for disease management adherence and onboarding patients
- Aptar Pharma is finalist for four CPhI pharma awards
- Aptar Seeks FDA Emergency Use Authorization for Decontaminating N95 Masks with ActivShield
- Aptar Pharma Partners with Lupin to launch India’s first connected smart device for respiratory disease, ADHERO
- Aptar Pharma’s Nasal Unidose Device approved by US FDA for new nasal seizure rescue treatment
- Aptar Pharma to host three insightful Learning Lab sessions
- Aptar Pharma showcases expanded portfolio of respiratory innovations and services
- Aptar Pharma’s preservative-free multidose dispenser approved in the US for Allergan’s REFRESH RELIEVA PF artificial tear formulation
- Aptar Pharma's Nanopharm wins Excellence in Pharma Award for SmartTrack
- Aptar Pharma highlights expanded services platform
- Aptar Pharma's nasal unidose device approved for Tosymra sumatriptan spray
- Aptar’s Nasal Unidose Device approved by US FDA
- Aptar acquires Nanopharm and Gateway Analytical, broadening pharma services platform to accelerate customer drug development
- Aptar Pharma's Freepod nasal spray device with GlaxoSmithKline's Otrivin wins prestigious WPO WorldStar 2019 award
- Aptar Pharma co-organizer and diamond sponsor of RDD Europe 2019 conference in Estoril, Portugal
- Aptar Pharma's bidose nasal drug delivery device approved by US FDA for breakthrough treatment of depression
- Aptar Pharma's preservative-free multidose dispenser approved across Europe for Santen's Taflotan/Saflutan prescription treatment
- Aptar Pharma QuickStart Injectables wins Industry Innovation Award at Pharmapack 2019
- Aptar Pharma is bringing the respiratory world together
- Aptar Pharma showcases PureHale and QuickStartTM Injectables product launches
- Aptar Pharma co-organizes the third edition of RDD Asia
- Aptar Pharma QuickStart, an injectable device development kit, to launch at CPhI Worldwide
- Aptar Pharma launches PureHale, a new portable and ready-to-use upper respiratory drug delivery solution
- Join Aptar Pharma's live webinar "Good medicine: Solutions for sensitive injectable formulations"
- Aptar Pharma to host live webinar on decoding the FDA's recent combination drug product guidance
- Aptar Pharma's Preservative-Free Multidose Dispenser approved for anti-allergy treatment by French regulatory agency ANSM
- Aptar Pharma unveils innovative inhalation drug delivery solutions
- Aptar Pharma to Unveil Inhalation Drug Delivery Solutions at CPhI China 2018
- Aptar Pharma to Host Connected Health Webinar “Digital Healthcare: Are You Ready to Connect?” on February 22
- New technologies in ophthalmic drug delivery webinar hosted by Aptar Pharma
- Aptar Pharma's electronic lockout device approved by EMA
- Pulmonary and Nasal Drug Delivery Experts to attend RDD Europe 2017
- Pulmonary and nasal drug delivery experts to attend RDD Europe 2017
- Aptar Pharma nears completion of elastomer component capacity in North America
- Preservative Free Multidose Dispensing of Eye Care Medication
- Aptar Pharma and RDD Online co-organize the second edition of RDD ASIA in Goa, India
- Aptar Pharma announces development and license agreement with BD to bring a novel auto-injector to market
- Serumony Featured on Sothys’ New Wrinkle Corrector
- Aptar Pharma's preservative free multi-dose ophthalmic squeeze dispenser launches in the U.S.
- Aptar Pharma provides unit-dose nasal spray technology for treatment of opioid overdose
- Aptar Pharma launches eDose counter for MDIs integrating a proprietary sensing technology
- Aptar Pharma’s Ophthalmic Squeeze Dispenser – Innovation based on experience
- Aptar Pharma presents a step change in the performance of DF30Plus for pMDIs incorporating COC
- The tenth anniversary of RDD Europe: A great success for the international Respiratory Drug Delivery community